Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 28.94
-0.16 (-0.55%)
May 20, 2026, 11:25 AM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 12.89 billion as of May 19, 2026. Its market cap has increased by 94.39% in one year.
Market Cap
12.89B
Enterprise Value
12.92B
Revenue
1.00B
Ranking
n/a
PE Ratio
121.93
Stock Price
28.94
Market Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 12.89B, a decrease of -67.01%. That is a compound annual growth rate of -15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 12.86B | 7.91% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 13.73B |
| Shenzhen Hepalink Pharmaceutical Group | 13.54B |
| Zhejiang Medicine | 13.41B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.19B |
| Hubei Hongyuan Pharmaceutical Technology | 12.75B |
| Shanghai Yizhong Pharmaceutical | 12.66B |
| Guobang Pharma | 12.65B |
| Zhejiang Hisun Pharmaceutical | 12.61B |